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1. Introduction 
 
The function of the immune system is to protect the host against any diseases. To accomplish 
this goal, the immune system has to perform four major tasks [1]. First, it has to recognize poten-
tially harmful disease-causing agents by detecting and binding antigens of invading pathogens. 
This task is fulfilled by both the innate and the adaptive immune system. The second task is to 
stop the disease and destroy all dangerous substances, which is carried out by immune effector 
functions, such as antibodies and the complement system.  A further task the immune system has 
to perform is to regulate immune responses to avoid an overreaction (e.g. allergies) and a subse-
quent damage of its host. Finally, the immune system should also protect against re-emerging 
pathogens. Therefore, the adaptive immune system provides an immunological memory, which 
allows immune reactions with the same pathogen to be much stronger and faster at a second con-
tact. 
 
Plenty of pathogens are already repelled by physical barriers of the human body, such as the skin 
and ciliated epithelia. In addition also chemical barriers, such as acids and enzymes, prevent in-
fectious agents to enter the body. Only if pathogens can pass these two barriers, innate and adap-
tive immune responses are activated. 
 
 
1.1 Innate Immunity 
 
The innate immune system reacts immediately and eliminates most of the pathogens. In contrast, 
the adaptive immune system reacts more slowly (days not hours), but clears the infection much 
more efficiently. 
  
 
1.1.1 Cells of the innate immunity 
 
Innate immunity contains a wide variety of cells of hematopoietic origin (Fig. 1). All cells of the 
innate immune system derive from pluripotent hematopoietic stem cells in the bone marrow. 
These pluripotent stem cells give rise to common myeloid progenitor cells, which then differen-
tiate into either granulocyte/macrophage progenitors or megakaryocyte/erythrocyte progenitors. 
Moreover, granulocyte/macrophage progenitors then give rise to polymorphonuclear leukocytes, 
such as neutrophils, eosinophils, basophils and monocytes. These ‘moving cells’ reside in the 
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blood until an inflammation occurs. If inflammation occurs, the cells are guided by cytokines 
and chemokines to the site of inflammation. Furthermore, monocytes continually migrate to the 
tissue without inflammation and differentiate into macrophages. Macrophages, dendritic cells 
and mast cells (the precursor of mast cell is still not known) belong to tissue-residing cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Cells from both the adaptive and the innate immunity derive from a pluripotent hematopoietic stem 
cell in the bone marrow. (Murphy et al., Janeway’s Immunobiology 2008) 
 
Eosinophils and Basophils 
The exact function of eosinophils and basophils is still in question. There is increasing evidence, 
that their function in innate immunity is to eliminate parasites, which are too big to be ingested 
by macrophages or neutrophils. When they are activated, they start to release their granules, 
which contain toxic proteins and enzymes. In addition, they have been attributed a role in aller-
gic inflammatory reactions as well. 
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Mast Cells 
As already mentioned above, the precursor of mast cells is still unknown. Mast cells contain 
granules, which are released upon contact with e.g. parasitic worms. Furthermore, mast cells 
release tumour necrosis factor (TNF) α in response to bacteria. Secreted TNFα then induces an 
influx of neutrophils to the site of inflammation [2]. 
 
Dendritic Cells 
Dendritic Cells are, like macrophages and neutrophils phagocytic cells, which participate in the 
innate immune response by clearing pathogens through phagocytosis and macropinocytosis. In 
addition, they play an important role in the adaptive immune response. After encountering invad-
ing pathogens, dendritic cells have the ability to activate T-lymphocytes of the adaptive immu-
nity.  
 
Neutrophils 
Neutrophils are one out of three types of phagocytic cells and are the most abundant cells in the 
innate immune system. After encountering an infection, released cytokines and chemokines (e.g. 
from macrophages) guide neutrophils to the site of inflammation. They migrate into the tissue, 
ingest pathogens by phagocytosis and efficiently destroy them [3]. 
 
Macrophages 
Macrophages reside in all tissues. They arise from circulating monocytes. Similar to neutrophils, 
their major task is phagocytosis and thereby clearance of pathogens and cellular debris. Addi-
tionally, macrophages also interact with the adaptive immune system by presenting antigens on 
their surface. Like other cells, macrophages express specific markers on their surface (CD14, 
CD11b and F4/80) and can therefore be easily identified with specific antibodies [4]. 
Formerly, activated macrophages could be divided into M1 and M2 macrophages. M1 macro-
phages are described as classically activated macrophages, whereas M2 macrophages are consid-
ered alternatively activated  [5]. M1 polarization is induced through ligation of certain pattern-
recognition-receptors (PRRs) and interferon-γ (INF γ). Moreover, it was recently suggested [6] 
that macrophages should be divided into three different groups, because M2 macrophages are a 
heterogeneous group, which differ dramatically in their biochemical and physiological proper-
ties. Therefore, it was suggested to divide M2 macrophages into a) wound-healing (triggered by 
interleukin-4 (IL4) and/or IL13) and b) regulatory macrophages (triggered by immune com-
plexes and TLR ligands).  
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In my research project, we mainly used macrophages derived from bone marrow cells stimulated 
with M-CSF , and they have been shown to exhibit characteristics of M2 macrophages.   
 
 
1.2 Pattern-Recognition-Receptors (PRRs)  
 
Cells of the innate immune system, especially macrophages, recognize pathogenic invaders by 
germline encoded pattern-recognition-receptors. Those PRRs bind to, amongst microbial species 
highly conserved structures called pathogen-associated-molecular-patterns (PAMPs). The group 
of PRRs contains actually four different classes of receptors [7]. One class is the RIG-I-like re-
ceptor (RLRs) family, which recognize dsRNA as for example the genomic RNA of certain vi-
ruses [8]. Another class is the NOD-like receptor (NLRs) family. These receptors are located in 
the cytoplasm and detect structures of bacterial peptidoglycans [9]. C-type lectin receptors 
(CLRs) are a third family of PRRs, which  recognizes β-glycans of fungi [10] and carbohydrates 
of microorganism [11]. The last, and for this diploma thesis most important class of PRRs, is the 
family of Toll-like receptors that will be described in more detail below. Additionally scavenger 
receptors, such as scavenger receptor A (SR-A) and CD36, belong to the PRRs [12]. In contrast 
to the four classes of PRRs, no signalling pathway is described for SR-A. However, there is evi-
dence that SR-A ligands are signalling through TLRs [13]. 
 
Toll-like receptors 
Toll was first discovered in the development of drosophila, in which it triggers anti-fungal re-
sponses [14]. Subsequently ten similar receptors (all of them involved in pathogen detection) 
were identified in the human body [15]. TLR1,2,4,5 and 6 are expressed on the cell surface, 
whereas TLR3,7,8,9 and 11 are localized intracellular. Most TLRs dimerize upon stimulation. 
TLR 3,4 and 8 act as homodimers, whereas TLR2 acts as a heterodimer together with TLR1 or 
TLR6.  
When stimulated, TLR4 homodimerizes on the plasma membrane and associates with CD14 and 
MD2 to form the Lipopolysaccharide (LPS)-receptor [1]. Intracellularly, TLR4 is linked to TI-
RAP or TRIF and could signal through either the MyD88-dependent or the TRIF-depending 
(also known as MyD88-independent) pathway, respectively. Both pathways finally activate tran-
scription factors and trigger the upregulation of inflammatory genes. 
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The most prominent ligand for TLR4 has been first described by Poltorak et al. in 1998 as the 
bacterial endotoxin Lipopolysaccharide (LPS) [16]. LPS first binds to CD14 and subsequently to 
the MD2/TLR4 complex. 
 
TLR2 
TLR2 forms heterodimers with TLR1 or 6. Moreover, pathogen recognition by TLR2 is strongly 
enhanced by the co-receptor CD14 [17]. Intracellularly, it is linked to TIRAP and hence signals 
only through the MyD88-dependent pathway. 
TLR2 is involved in the recognition of a wide array of microbial molecules. LTA (a major con-
stituent of the gram positive cell wall) is probably the best known ligand for TLR2 [18]. Fur-
thermore, TLR2 participates in the recognition of some types of LPS [19]. 
 
 
1.3 Oxidation Specific Epitopes 
 
Oxidative reactions are crucial for survival. During oxidative reactions, reactive oxygen species 
(ROS) are formed, which have important roles in homeostasis and cell signalling. Moreover, 
they also have the ability to damage proteins and lipids. Under normal circumstances, antioxi-
dant mechanisms like vitamin C, vitamin E and superoxide dismutases (SOD) buffer the effect of 
ROS and therefore maintain a balance. Enhanced formation of ROS, as it occurs for example 
during inflammation, can result in a state referred to as “oxidative stress”. If lipids are targeted 
by ROS, lipid peroxidation can occur. Lipid peroxidation mainly affects unsaturated lipids, as 
they offer highly reactive ethylene-bonds. Many unsaturated lipids are to be found in the cell 
membrane. When cells undergo apoptosis, unsaturated lipids (polyunsaturated fatty acids of 
phospholipids) become oxidized and give rise to highly reactive products; amongst them, differ-
ent highly reactive aldehydes, including malondialdehyde (MDA) and 4-hydroxynonenal, which 
can form covalent adducts with the ε-aminogroups of lysines or aminogroups of phospholipids, 
such as phosphatidylethanolamine (Fig. 2). These newly generated “oxidation specific epitopes” 
are found on apoptotic and necrotic cells, but not on viable cells. Furthermore microparticles 
(apoptotic blebs) and oxidized LDL, but not LDL, carry them as well [20, 21]. These epitopes 
have been shown to be recognized by the innate immune system via natural antibodies, scaven-
ger receptors and innate effector proteins. Additionally, some oxidation specific epitopes are 
mediate effects via TLRs (eg. OxPL stimulates TLR4 [22]). Due to the fact that oxidation spe-
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cific epitopes are recognized by the same receptors as PAMPs, they are similarly classified as 
damage (danger) associated molecular patterns [23]. 
 
Fig. 2 Oxidation specific epitopes are major targets of innate immunity (modified from Binder CJ et al., 
JLR 2005). 
 
 
1.3.1 Malondialdehyde 
 
Malondialdehyde (MDA) is one major secondary product of lipid peroxidation [24]. Similarly, 
phosphocholine (PC) containing oxidized phospholipids, oxidized cardiolipin (OxCL) and 4-
hydroxynonenal have been shown to form adducts as well. Aldehydes, generated during lipid 
peroxidation are highly reactive and attack targets intra- or extracellularly. Together with acetal-
dehyde (AA), MDA forms the malondialdehyde-acetaldehyde-adduct (MAA) that are believed to 
be the biologically most active MDA-epitopes. MDA-epitopes are found in various pathological 
settings like atherosclerosis, acute lung injury, Alzheimer’s disease, rheumatoid arthritis and 
apoptotic cells (Fig 3). 
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Fig. 3 Malondialdehyde-acetaldehyde is found in various pathological settings. 
 
 
In vitro, mainly four different MDA-adducts are generated upon reaction of MDA with a carrier 
protein (Fig 5), depending on the pH and the supply of acetaldehyde (AA). If MDA reacts with 
an aminogroup on lipids or proteins at a neutral pH of 7.4, mainly simple (A) and cross-linking 
(B) adducts are generated. Both adducts are non-fluorescent. Bovine serum albumin modified 
this way is referred to as MDA-BSA in this thesis. If MDA reacts with aminogroups under acidic 
conditions, 3,5-diformyl-1,4-dihydropyridine-4-yl-pyridinium (FHP) -adducts (D) are generated. 
FHP is a fluorescent, cross-linking adduct. Modification of primary aminogroups with AA and 
MDA  in acidic conditions, generates the malondialdehyde-acetaldehyde adduct (MAA), which 
is a ring structure also referred to as 4-methyl-1,4-dihydropyridine-3,5-dicarbaldehyde 
(MDHDC)[25] (C). 
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Fig. 4 MDA is a highly reactive aldehyde, which reacts immediately and therefore generates different 
adducts (A,B: MDA-BSA, C: MAA-BSA, D: FHP-BSA) 
 
MDHDC is fluorescent but in contrast to FHP involves only one aminogroup. BSA modified 
with acetaldehyde and MDA as just described will be named MAA-BSA in this thesis.  
 
In this Master Thesis, I aim to define malondialdehyde-acetaldehyde-adduct (MAA) as a novel 
danger-associated-molecular-pattern (DAMP) and delineate the cellular responses of macro-
phages to it. DAMPs are endogenous danger signals that induce inflammatory responses in ab-
sence of microorganisms. For this reason, the induced response is called sterile inflammation. I 
will provide evidence that MAA acts as a danger signal, hence is recognized by various PRRs 
and has to be cleared effectively by the immune system to avoid chronic inflammation. The ob-
tained insights suggest a crucial role of TLR4 and TLR2 for the responses towards MAA. Fur-
thermore, CD14 is necessary for MAA signalling. Additionally I will present data that suggest 
that MAA-BSA binds to TLR2.  
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2. Material & Methods 
 
2.1 Material 
 
Mice 
 
TLR4-/-, C57BL/6, SR-A-/- and CD36-/- were purchased from The Jackson Laboratory. TLR2-/- 
and CD14-/- mice were a generous gift from Sylvia Knapp. Mice were housed under conven-
tional conditions and fed regular rodent chow. All animal experiments were performed in accor-
dance with relevant guidelines and regulations. 
 
Cells, chemicals, plates and buffers 
 
The human monocytic cell line THP1 and the murine macrophage cell line RAW267.1 (RAW) 
were grown according to ATCC protocols. Mouse bone marrow derived macrophages (BMDM), 
mouse peritoneal macrophages were isolated as described below. Dulbecco’s Modified Eagle 
Medium (DMEM), RPMI 1640 + Glutamax (contains a stabilized form dipeptide from L-
glutamine, L-alanyl-L-glutamine, that prevents degradation and ammonia build-up even during 
long-term cultures) (RPMI) and Hank's Buffered Salt Solution (HBSS) media were purchased 
from Invitrogen and supplemented with 10% of heat-inactivated fetal bovine serum (FBS, Pepro-
tech), 1% Penicillin/Streptomycin (P/S) (Sigma), 1% HEPES (Sigma) and 0.1% Gentamycin 
(Invitrogen). Macrophage colony-stimulating factor (MCSF) was purchased from PeproTech. 
BCA protein assay kit was provided by Pierce. 
ELISA plates (Immuno Maxi Sorp) were obtained from Nunc and microfluor plates from 
Thermo Scientific. PTS cartridges for endotoxin test (LAL test) were purchased from Charles 
River. Stripping buffer was obtained from Thermo Scientific. 
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SOC medium (1000ml) 
 
20g Bacto 
5g Bacto Yeast Extract 
2ml 5M HCl 
10ml 1M MgCl2 
10ml 1M MgSO4 
2,5ml 1M KCl 
20ml 1M Glucose 
filled up with H2O to 1000ml 
 
Protein Lysis Buffer 
50mM HEPES 
150mM NaCl 
5mM EDTA 
1% NP-40 
50mM NaF 
1mM Na3VO4 
1mM PMSF 
1:25 Complete 
H2O 
 
Protein Wash Buffer I 
50mM HEPES 
500mM NaCl 
5mM EDTA 
1% NP-40 
50mM NaF 
1mM Na3VO4 
1mM PMSF 
1:25 Complete 
H2O 
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Protein Wash Buffer II 
50mM HEPES 
500mM NaCl 
5mM EDTA 
H2O 
 
10x Running Buffer (1l) 
144g Glycin 
33g TRIS 
10g SDS 
pH 8,3 (HCl) 
Transfer Buffer 
5,89g TRIS 
9,93g Glycine 
0,375g SDS 
 
HEBS Buffer 
400ml H2O 
8g NaCl 
0,2g Na2HPO4 
6,5g HEPES (Sigma) 
 
1x TAE buffer 
40 mM Tris acetate 
1 mM EDTA 
 
Protein Gel 
4x Lower Buffer 
1,5M TRIS 
0,4% SDS 
pH 8,8 (HCl) 
 
 
 
 18
4x Upper Buffer 
0,5M Tris.HCl 
0,4% SDS 
pH 6,8 (HCl) 
 
Lower Gel 1,5mm 
8,2ml 30% acrylamid 
7ml H2O 
5ml 4x Lower Buffer 
200µl APS 
10µl Temed 
 
500µl isopropanol was added on the lower gel until it became solid, then discarded before addi-
tion of upper gel. 
 
Upper Gel 1,5 mm 
2,4ml 30% acrylamid 
7,2ml H2O 
3,2ml Upper Buffer 
128µl APS 
10µl Temed 
 
 
 
2.2 Methods 
 
Modification of bovine serum albumin (BSA) 
 
MAA-BSA 
To generate MAA-BSA, a 0.5M Malondialdehyde (MDA) solution was prepared by adding HCl 
(0.01M) and H2O to MDA and incubated 10 min at 37°C until the colour turned slightly yellow. 
After turning yellow, the pH of the MDA solution was adjusted to 4.8. Meanwhile, to facilitate 
pipetting, the highly volatile acetaldehyde (AA) was diluted 1:4 in phosphate buffered saline 
(PBS) at pH4.8. MDA (0.1M), BSA or L-polylysine (20mg) and AA (0.015M) were mixed and 
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the pH was adjusted to 4.8. Then the reaction mix was incubated at 37°C for 4h and dialyzed 
against PBS pH7.4 at 4°C o/n. 
 
MDA-BSA 
The modification was done as described for MAA-BSA, but without addition of AA and the pH 
was adjusted to 7.4 instead of 4.8. Subsequently, the reaction mix was incubated for 45min at 
37°C. 
 
FHP-BSA 
The modification was done as described for MAA-BSA, but without AA and the pH was ad-
justed to 5 instead of 4.8. Subsequently, the reaction mix was incubated for 4h at 37°C. 
 
AA-BSA 
The modification was done as described for MAA-BSA, but without adding MDA, the pH ad-
justed to 4.8 and the reaction mix incubated 4h at 37°C. 
 
 
Modification of LDL 
Copper oxidation and MDA modification of LDL were carried out by Maria Ozsvar-Kosma as 
described in detail previously [26]. 
 
 
Bicinchoninic acid assay (BCA) 
The BCA assay is commonly used to quantify protein in solutions. The protein bonds from each 
protein reduce Cu2+ to Cu1+. Thereby, the amount of Cu1+ ions is proportional to the amount of 
protein. In the next step, Cu1+ ions are bound by each two molecules of bicinchoninic acid, form-
ing a violet complex. 
 
The working reagent was prepared by mixing solution A to solution B in a 1:50 ratio. 25µl of 
each sample and standard (both diluted 1:5 and 1:25 in H2O) were mixed with 200µl of the 
working reagent. After this, the samples were incubated for 30min at 37°C. Subsequently the 
absorbance was measured at a wavelength of 562nm using a Biotek Synergy 2 plate reader. 
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Measurement of fluorescence 
2µg of modified BSA/polylysine were resuspended in 200µl of H2O and fluorescence was meas-
ured at the wavelengths 355(excitation)/460nm (emission) using a Biotek Synergy 2 plate reader. 
 
 
Trinitrobenzene sulphonic acid (TNBS) Assay 
This assay measures the availability of free amino groups. 
 
First, 50µg of protein were diluted in 250µl H2O and 500µl of 4% bicarbonate buffer (pH8.5) 
were added. Subsequently, 50µl of picrylsulfonic acid were added, mixed and incubated for 60 
minutes at 37°C. Following the incubation, 200µl of 1N HCl and 100µl of 10% SDS were added 
and well mixed. After 15 minutes  the absorbance of the reaction mixture was measured at a 
wavelength of 340nm using a Biotek Synergy 2 plate reader. 
 
 
Generation of polylysine and MAA-polylysine beads 
First, 5ml of bead suspension (N-hydroxysuccinimide (NHS) activated Sepharose 4 fast flow in 
isopropanol) were activated by washing with 45 ml 1mM HCl. The suspension was centrifuged 
for 5 min at 800rpm and beads were resuspended in 8ml polylysine/MAA-polylysine (2mg/ml in 
PBS, pH 7.4). Following an incubation for 4h at room temperature (RT), beads were sedimented 
as before, the supernatant (SN) was aspirated and the remaining reactive NHS-groups were 
blocked by incubation for 2h at RT in 40ml of 0.1M Tris-HCl pH 8.5. Subsequently, beads were 
sedimented by centrifugation and washed in 16ml of 0,1M acetate buffer, 0.5M NaCl, pH 4.5. 
The suspension was distributed to 2x 15ml tubes and centrifuged again for 1min at 1000 rpm. 
Then SN were aspirated and 8ml of 0.1M Tris-HCl, pH 8.5 were added. The acetate-tris-wash 
cycle was repeated 5x (6 in total), beads were combined and stored as a 1:1 suspension in PBS, 
pH 7.4. 
 
 
Antibody depletion with MAA-PL-beads  
Microfluor round bottom 96-well ELISA plates (white) were coated with 50µl/well of CuOx-
LDL, MDA-LDL or MAA-BSA (1µg/ml) o/n at 4°C. On the following day coated plates were 
washed 4x with PBS and blocked 30min at RT with 100µl/well of PBS 1% BSA. Subsequently 
plates were washed 4x with PBS. The beads (1:1 suspension in PBS) were mixed with 2x stock 
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solutions of antibodies (EO6 [2,34mg/ml], EO14 [0,2mg/ml] and LRO4 [0,75mg/mL]) (2µg/ml). 
Following incubation for1h, the suspension was sedimented by centrifugation (1min at 230g) and 
50µl of the supernatant were added to the plate o/n. On the next day, the plate was washed 4x 
with PBS and incubated 1h with a secondary antibodyagainst mouse IgM coupled to alkaline 
phosphatase (αIgM-AP diluted 1:30,000 in PBS 1% BSA, Sigma-Aldrich). The plate was 
washed 4x with TBS to remove phosphates and finally LumiPhos (diluted 1:3 in H2O) was added 
for 90min at RT in darkness. Afterwards chemiluminescence was measured using a Biotek Syn-
ergy 2 plate reader. All washing steps were performed on a Biotek microplate washer model 
ELx405. 
 
 
ELISA based assay for the binding of Fc-TLR2 to MAA 
Microfluor round bottom 96-well ELISA plates (white) were coated o/n at 4°C with 50µl/well 
(1µg/ml) of MAA-BSA, BSA or corresponding controls (diluted in PBS). On the next day, 
coated plates were washed with PBS and blocked for 60min with 100µl of PBS containing 1% 
BSA. After washing with PBS, the plates were incubated for 120min at RT with 50µl of the 
TLR2 Fc chimera (20µg/ml in PBS), washed again with PBS, and then 50µl of monoclonal α Fc 
IgG-biotin (Sigma; 1:50000 in PBS) were added for 60min at RT. Subsequently, the plates were 
washed with TBS and incubated with 25µl of Lumiphos for 90min in the dark. Finally the 
chemiluminescence was measured at a wavelength of 530nm. All washing steps were performed 
on a Biotek microplate washer model ELx405. 
 
 
Competition of MAA-BSA with TLR2 Fc Chimera 
Microfluor round bottom 96-well ELISA plate (white) were coated with 50µl/well of MAA-
BSA, BSA or Pam3CSK at a concentration of 1µg/ml (in PBS) for 1h at 37°C. Subsequently, 
plates were washed 4x with PBS and thereafter blocked for 1h at RT with PBS 1%BSA. TLR2 
Fc chimera (1µg/ml in PBS 1% BSA) was pre-incubated with BSA or MAA-BSA to minimize 
binding capacities for 1h. After blocking, the plate was washed again 4x with PBS, 50µl of the 
pre-incubated Fc chimera were added and incubated over night (o/n) at 4°C. On the following 
day plates were washed 4x with PBS, and monoclonal α Fc IgG-biotin (Sigma; 1:50,000 in PBS) 
was added and incubated for 1h at RT. Thereafter plates were washed 4x with PBS-EDTA and 
1x with H2O, and chemiluminescence was measured using LumiPhos as described above. All 
washing steps were performed on a Biotek microplate washer model ELx405. 
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IL-8 ELISA 
For the detection of IL-8 in cell culture supernatants, I used the human IL-8 ELISA set from 
Becton, Dickinson and Company (BD). Maxisorp 96-well flat bottom  plates (Nunc, transparent) 
were coated with 100µl IL-8 capture AB (in NaHCO3 buffer; (1:250) o/n at 4°C. On the next day 
paltes were washed 3x in PBS 0.05% Tween 20 and blocked for 1h at RT with PBS 10% FCS. 
Then plates were washed again 3x with PBS 0.05% Tween 20, and 100µl of samples and stan-
dards (both diluted in PBS 10% FCS; 1:1 dilution series for standard starting with 200pg/ml) 
were added and incubated for 2h at RT. Subsequently, plates were washed 6x with PBS 0.05% 
Tween 20, and 100µl of biotinylated anti-human IL-8 Ab (1:250) + streptavidin-HRP in PBS 
10% FCS) were added. Plates were incubated for 1h at RT, followed by 6 washing steps with 
PBS 0.05% Tween 20  and addition of 100µl of TMB solution (Peroxidase substrate; TMB A 
and TMB B (Lumigen, Inc) were mixed 1:1). After 20 min the reaction was stopped with 100µl 
1N H2SO4 and the OD (450/570nm) was measured using a Biotek Synergy 2 plate reader. All 
washing steps were performed on a Biotek microplate washer model ELx405. 
 
 
KC/MIP-2 ELISA 
For the detection of KC/MIP-2 in cell culture supernatants, I used the DuoSET ELISA develop-
ment kit from R&D. Nunc Maxisorp plates were coated with 100µl of capture Abs [500µg/ml] 
(in PBS) o/n at 4°C. On the following day, plates were washed 3x in PBS 0.05% Tween 20 and 
blocked for 1h at RT with PBS 1% BSA. Afterwards plates were washed again 3x, 100µl of 
samples and standards (both diluted in PBS 1% BSA; starting dilution of standards at 
1000pg/ml) were added and incubated for 2h at RT.  Plates were washed 3x and subsequently 
100µl of biotinylated detecting Abs [50µg/ml] in PBS 1% BSA) were added. Following another 
incubation of 2h at RT, the plate was washed 3x, 100µl streptavidin-HRP solution (R&D; 1:200 
in PBS 1% BSA) were added and incubated for 20min. Subsequently plates were washed 3x, 
100µl of TMB solution were added, incubated for 20min and finally the reaction was stopped by 
adding 100µl 1N H2SO4. Then the OD (450/570nm) was measured using a Biotek Synergy 2 
plate reader. All washing steps were performed on a Biotek microplate washer model ELx405. 
 
 
Limulus amebocyte lysate (LAL) -Test 
The assay is based on limulus amebocyte lysate, which is extracted from blood cells from Limu-
lus polyphemus (horseshoe crab), and is used to detect bacterial endotoxin or lipopolysaccharide 
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(LPS).  This lysate contains enzymes that are activated by endotoxin and subsequent split the 
chromophore paranitro aniline (pNA) from the chromogenic substrate, producing a yellow col-
our. 
4x 25µl of the sample (diluted to its working concentration in PBS) were tested using PTSTM 
cartridges (Charles River; detection limit >0.05EU/ml). The assay was performed and evaluated 
on Endosafe®-PTSTM from Charles River. If the value is below 0.05 EU/ml, the sample is con-
sidered  endotoxin free. 
 
 
Stimulation of THP1 cells 
THP1 cells were diuled to a concentration of 5x105 cells/ml in RPMI. Subsequently, 100µl of 
this suspension was added into a 96-well v-bottom plate. The suspension was centrifuged for 
5min at 300g and the supernatant (SN) discarded. Finally the pellet was resuspended in 100µl 
stimulation medium (RPMI  + BSA or MAA-BSA) and transferred to a 96 u-bottom well tissue 
culture plate. After incubation for the indicated time at 37°C / 5%CO2, cell suspension was trans-
ferred to 96well v-bottom plate, cells were pelleted by centrifugation (5min 300g) and the SNs 
were harvested for analysis by ELISA or stored at -80°C. 
 
 
Apoptotic Assays 
 
Staurosporine 
1µg/ml of staurosporine was added toTHP1 cells and incubated o/n at 37°C / 5% CO2. 
 
Etoposide 
1µg/ml of etoposide was added to THP1 cells and incubated o/n at 37°C / 5% CO2. 
 
UVA/UVB 
30x106 cells (THP1 and RAW) were resuspended (adherent cells were scraped before counting) 
in 5ml PBS and transferred to a 10cm dish. Following irradiation (UVA: Sellamed 3000; UVB: 
Waldmann Medizin Technik) without lid for the desired time, cells were centrifuged for 5min at 
300g and resuspended in 10ml RPMI without FCS. Subsequently, the cells were allowed to un-
dergo apoptosis by o/n incubation at 37°C. 
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Flow cytometric analysis of apoptotic cells 
Apoptotic cells were resuspended à 1x106 cells/ml. 1ml of cells were centrifuged for 5min at 
500g and resuspended in 99µl PBS 1% BSA. Then 1µl of α-CD16/CD32 (1:200; BioLegend) 
was added and incubated for 15min at RT to block Fc-receptors. Subsequently, 700µl of PBS 1% 
BSA were added and the suspension was distributed to micronic tubes (100µl per tube). Follow-
ing a 5min centrifugation  at 500g, the SN was aspirated and 100µl of LRO4 [0,75mg/ml] 
(1:438; MDA-specific mouse monoclonal IgM) or α-KLH [0,5mg/ml](1:100; BioLegend; iso-
type control) were added. After an incubation of 30min at 4°C 300µl of PBS 1% BSA were 
added, centrifuged for 5min at 500g and 100µl of α-IgM-APC (Allophycocyanin) [0,5mg/ml] 
(1:800; BD) were added. The suspension was incubated for 30min at 4°C, 300µl of PBS 1% 
BSA were added and again centrifuged for 5min at 500g. Afterwards cells were resuspended in 
100µl of 7AAD+Annexin V solution (1µl of Annexin V (1:100; BD) + 1µl of 7AAD (1:100; 
BD) + 98µl of PBS 1% BSA) and incubated for 10min at RT. Finally 400µl of Annexin V buffer 
(PBS 1% BSA; 2mM CaCl2) was added. Flow cytometry was performed on a FACSCalibur 
(BecktonDickinson). All antibodies were diluted in PBS 1% BSA. 
 
 
Pulldown Assay 
 
Cell Lysate 
First,  adherent RAW cells  were washed 2x with ice-cold PBS. Then the dish was placed on ice 
and 600µl of protein lysis buffer (see material) were added. Following scraping of the cells in 
lysis buffer, the lysate was homogenized by repeated pipetting. To remove cellular debris, the 
solution was transferred to an eppendorf tube and centrifuged for 10min at 18000g at 4°C. The 
supernatant was transferred to a new eppendorf tube and used for analysis after protein quantifi-
cation by BCA assay. 
 
Pulldown Assay 
Eppendorf tubes were prepared with either 80µl of MAA beads (1:1 suspension in PBS) or 80µl 
of polylysine beads (as negative control; 1:1 suspension in PBS). Then 2ml of cell lysates were 
added to each tube and incubated for 2h at 4°C on a roller mixer. After this, the suspension was 
transferred to spin columns (90µm filters, Mobicol) and centrifuged for 2min at 200g at 4°C. The 
flow through was discarded, 500µl of protein wash buffer I were added, followed by centrifuga-
tion for 2min at 200g at 4°C. Again the flow through was discarded and the washing cycles were 
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repeated 3 times. Then columns were washed 2x with protein wash buffer II (buffer II was ap-
plied to the walls of the columns from the top in a circular fashion, to reduce the risk of possible 
contamination with detergens from the lysis buffer that could interfere with the shotgun proteo-
mic analysis). Afterwards beads were resuspended in 1ml washing buffer II, transferred to a new 
eppendorf tube and centrifuged for 1min at 100g. Subsequently, supernatants were aspirated and 
samples boiled in 80µl NuPage LDS sample buffer (Invitrogen) + β-Mercaptoethanol (28mM) 
for 5min at 95°C. Finally, supernatants were taken to new eppendorf tubes, boiled again for 5min 
at 95°C and samples were loaded an a 10% SDS gel. 
 
 
Silverstain of a SDS gel 
First the gel was fixed o/n in 50% methanol / 10% acetic acid. On the next day, the gel was 
washed 20min in 50% methanol and 2x 10min in H2O. Then it was sensitized for 30sec using 
0.02% sodiumthiosulfate (Na2S2O3.5H2O). Subsequently, the gel was washed 2x shortly in H2O 
and incubated 2x 10min in freshly prepared AgNO3 (0,1% AgNO3 in 4°C cold H2O). Afterwards 
it was rinsed 1x in H2O and developed in 3% Na2CO3 / 0,05% HCHO. The developing solution 
was exchanged if needed. The gel was developed until the background turned slightly brown. 
The reaction was stopped with 1% acetic acid and the gel was stored in 1% acetic acid at 4°C. 
 
 
Generation of bone marrow derived macrophages (BMDMs)  
Femurs and tibias from mice were harvested, cleaned, opened at..., and flushed with wash me-
dium (RPMI + 10% Pen/Strep) using a 25G-needle attached to a 10ml syringe. The cells were 
mixed by pipetting and passed through a 100µm filter. Following centrifugation for 10min at 
300g and resuspension in 2ml wash medium, 8ml Erythrocyte-Lysis-buffer (Morphisto) were 
added and incubated for 5min. Addition of 10ml culture medium (RPMI+FCS) was followed by 
mixing and centrifugation for 10min at 300g.  Then cells were washed 1x in 20ml culture me-
dium, centrifuged, resuspended in 10ml culture medium  and counted (54µl medium, 6µl trypan 
blue and 20µl cells). Finally, cells were resuspended in the calculated volume (1x106cells/ml for 
RNA isolation; 3x106cells/ml for ELISA), macrophage-colony-stimulating-factor (MCSF; 
1:1000) was added and subsequently cultured in cel culture dishes at 37C / 5% CO2. After 3 
days, 1 volume of medium + MCSF (1:500) was added. At day 6, the monolayer was washed 
twice with PBS and used for experiments. The differentiation was confirmed by staining cells for 
expression of CD11b by flow cytometry using an  anti-CD11b-APC (BioLegend). 
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Isolation of RNA 
RNA was isolated with Qiagen RNeasy Kits according to manufacturer’s instructions. 
 
 
cDNA generation  (High Capacity cDNA Reverse Transcription Kit; Applied Biosystems) 
 
Mastermix 
1µl RT buffer 
0,4µl dNTPs 
1µl random primer 
0,5µl RT 
2,1µl H2O 
 
Reaction mix: 
5µl mastermix 
5µl RNA 
 
Reverse transcription cycler programme (Eppendorf vapo.project thermal cycler) 
1) 25°C 25min 
2) 37°C 120min 
3) 85°C 5sec 
4) 4° unlimited 
 
cDNA was diluted 1:10 in H2O for RT-qPCR. 
 
 
Real Time quantitative PCR (RT-qPCR) 
Mastermix 
0,5µl Primer Mix (10µM forward primer, 10µM reverse primer in H2O) 
5µl SYBR Green (Peqlab) 
 
PCR reaction 
5,5µl mastermix 
4,5µl cDNA 
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PCR program 
1) 50°C 2min 
2) 94°C 10min 
3) 95°C 15sec 
4) 60°C 15sec 
5) 72°C 30sec 
6) 60°C 5min 
Steps 3-5 were repeated 39x. A melting curve was generated after the PCR to assess the quality 
of the product. 
 
 
Peritoneal Lavage 
To isolate resident peritoneal macrophages of mice, a peritoneal lavage was performed. Follow-
ing euthanasia, the peritoneal cavity was flushed with 10ml HBSS 2% FCS. Cells were detached 
by gentle shaking before recovery of the lavage fluid. Subsequently, the cell suspension was cen-
trifuged for 5min at 300 g and cells (macrophages) were resuspended in RPMI + FCS and 
seeded. In order to enrich for macrophages, cells were cultured in cell culture dishes over night 
and non-adherent cells were removed by washing with PBS on the next day. 
 
 
Intraperitoneal injections 
25µg/g body weight of MAA-BSA or 10x106 apoptotic cells/mouse were injected into the peri-
toneal cavity. After 2 or 5h, mice were sacrificed and a peritoneal lavage was peformed with 
10ml of PBS 1%BSA. After centrifugation for 10min at 300g, SN were analyzed by ELISA or 
stored at -80°C. Peritoneal cells were stained with anti-mouse CD11b-APC [0,5mg/ml] (1:800; 
Biolegend) and anti-mouse Ly6C-FITC [0,5mg/ml] (BioLegend; 1:200) for FACS analysis to 
elucidate specific cell influx into the peritoneal cavity. Monocytes are Cd11b+Ly6C- and macro-
phages are Cd11bhigh Ly6C-. Moreover, neutrophils are CD11b+ Ly6C+ and inflammatory mono-
cytes are CD11b+ Ly6Chigh. Additionally, cells were stained with anti-mouse Ly6G-PE 
[0,5mg/ml] (1:2000; BioLegend), to better distinguish between neutrophils (Ly6G+) and inflam-
matory monocytes (Ly6G-). 
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Western Blot 
 
Cell lysis 
Cell monolayers (12well) were washed 1x with 1ml ice cold PBS. Then 100µl of protein lysis 
buffer were added and lysates were homogenized by repeated passing through a 25G needle. 
Subsequently, lysates were placed on ice for 30min, centrifuged for 10min at 4°C and super-
natants were used for further analysis. 
 
Blotting, detecting and stripping 
A polyacrylamide gel was prepared as described before. The samples (30µl/slot) and the molecu-
lar weight marker (2µl/slot, Fermentas) were loaded and the gel was run at 120V for 1,5h. Af-
terwards, proteins were transferred from the gel to a nitrocellulose membrane (Whatman) using 
the BioRad TransBlot SD (semi-dry) system and the transfer buffer (described above). The blot 
was run for 30min at 15V. 
After blotting, the membrane was first blocked for 60min in TBS 0.05%Tween 5%milk. Subse-
quently the 1st AB (1:1000) in TBS 0.05%Tween 5% milk was added and incubated o/n at 4°C. 
On the following day the membrane was washed 3x 5min in TBS 0,05%Tween and then the 2nd 
AB (1:2000) in TBS 0,05%Tween 5%milk was added for 60min at RT. After washing 3x 10min 
in TBS 0.05%Tween, ECLplus (GE healthcare) was prepared according to manufacturer’s in-
structions (1ml reagent A + 25µl reagent B), the membrane was covered with 1ml of ECLplus 
and incubated 5min in the dark. Finally, the membrane was exposed and pictures were taken 
(Bio Rad Universal Hood II). 
To remove all antibodies that could interfere with further detections, membranes were stripped. 
First, membranes were washed in TBS 0,05%Tween 5% milk for 10min. Subsequently, the 
membranes were incubated for 20min in stripping solution (Thermo Scientific Prod #21059). 
After stripping, membranes were washed 2x for 5min in TBS 0,05%Tween and further treated as 
described above (blocking, 1st antibody, 2nd antibody, detection). 
 
Antibodies for Western Blot 
1st AB:  
P-p44/42 MAPK Mouse mAB [100µg/ml] (Cell Signalling) 
p44/42 MAPK Mouse mAB [100µg/ml] (Cell Signalling) 
2nd AB: 
αMouse-HRP [1mg/ml] (abcam) 
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Cloning 
 
Design of primers 
First, the coding sequence (CDS) of the gene of interest was identified on Pubmed 
(http://www.ncbi.nlm.nih.gov/pubmed/). Following, the CDS was copied into the primer3 source 
sequence window (http://frodo.wi.mit.edu/primer3/). Primers flanking a splicing site were de-
signed and blasted on the genome of interest. The E-value describes the random background 
noise. The lower the value, the more significant the hit is. Therefore the E-value should be 
around 0.015. 
 
PCR from original vector 
Primers were designed for the coding region including start and stop codons and restrictions sites 
were added. The annealing temperature of forward and reverse primer should differ max. 2°C. 
 
Primer 
MD2 attB1 primer fw. 
gggg aca agt ttg tac aaa aaa gca ggc tcc atg tta cca ttt ctg ttt ttt tcc 
MD2 attB1 primer re: 
gggg ac cac ttt gta caa gaa agc tgg gt cta att tga att agg ttg gtg 
 
40µl PCR  reaction to amplify coding insert from template plasmid 
8µl 5x GoTaq green buffer 
0,4µl 25mM dNTP 
2µl 10µM primer mix 
17,2µl H2O 
0,4µl GoTaq-Polymerase 
1µl template plasmid (40ng DNA) 
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PCR program 
1) 94°C 3min 
2) 94°C 30sec 
3) 65°C 30sec 
4) 72°C 1min 
5) 72°C 5min 
6) 4°C unlimited 
Steps 2-4 were repeated for 35x. 
 
Run Agarose Gel 
A gel containing 1% agarose in 1x TAE buffer  Gelstar (1:30,000) was prepared. Samples were 
loaded and the gel was run at 80V. Bands were visualized on Bio Rad Universal Hood II. 
Ineeded some cases, bands were excised under UV light. 
 
Extract DNA from Agarose Gel 
For the extraction of DNA from an agarose gel the QIAEX II kit from Qiagen was used. First, 
the DNA band from the agarose gel was excised weighed and 3 volumes of Buffer QX1 were 
added. QIAEX II beads were vortexed for 30 s, and 10µl were added to the sample followed by 
incubation for 10min at 50°C. During this incubation, the sample was vortexed every 2 minutes. 
Then the solution was centrifuged for 30 s at full speed. The pellet was washed with 500µl of 
Buffer QX1 and centrifuged again for 30 s. Subsequently, the pellet was washed twice with 
500µl Buffer PE, centrifuged for 30 s and air dried for 15min. Finally, DNA was eluted by vor-
texing the beads in 20µl H2O.  
 
EcoRI/SalI restriction digest 
1µl EcoRI (Roche) 
1µl SalI (Roche) 
5µl buffer H 
23µl H2O 
20µl  PCR product or vector 
 
Samples were incubated for 2h at 37°C. 
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Ligation 
The insert and vector were used in a volume ratio 3:1 
20µl reaction 
4µl 5x dilution buffer 
1µl digested vector 
3µl digested insert 
10µl 2x ligation buffer 
1µl T4 ligase 
The samples were incubated for 30min at RT 
 
Heat shock transformation into chemically competent XL1-blue bacteria 
15µl XL1-blue bacteria (thawed on ice for 15min) and 10µl ligation mix were combined on ice. 
The samples were incubated first for 30min on ice and subsequently 40sec at 45°C and 300rpm. 
Afterwards 250µl of SOC medium (preheated to 37°C) were added and incubated for 1h at 37°C, 
shaking at 200rpm. Finally 200µl of the bacteria were plated on amp-agar plates (50ng/ml am-
picillin) at 37°C o/n. On the next day the colonies were picked and inoculated o/n. 
 
 
Transfection of HEK293T cells 
On the day before transfection, HEK293T cells were washed in HBSS, trypsinized (Trypsin ob-
tained from Sigma) for 2 min and resuspended in 10ml of culture medium (DMEM+FCS). 1.5ml 
of culture medium containing 500,000 HEK293T cells were added to a 6 well plate. On the fol-
lowing day, the transfection mix was prepared: 
 
2µg DNA 
9µl CaCl2 (2M)  
61µl H2O 
The transfection mix was added drop wise into 71µl of HEBS buffer and incubated for 5min at 
RT. Afterwards the whole mix was added drop wise to the seeded cells. 
 
 
DNA/RNA quantification 
DNA/RNA concentrations were quantified using the Nanodrop spectrometer 2000C (Peglab) 
according to the manufacturer’s instructions . 
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DNA isolation Mini Prep 
The 5prime FastPlasmid Mini-Prep Kit (5prime) served for isolation of the plasmids amplified in 
E. coli. A single colony grown on a LB-Ampicillin plate was picked off and inoculated in a 2 ml 
liquid LB-Ampicillin culture. It was grown over night at 37 °C at 12g.The isolation was done 
according to the manufacturer’s instructions. The DNA was resuspended in 50µl H2O. 
 
 
DNA isolation Midi Prep 
For high-yield plasmid purification, PureLink Midi 50 kit from Invitrogen was used. A single 
colony grown on a LB-Ampicillin plate was picked off and inoculated in a 50 ml liquid LB-
Ampicillin culture. It was grown over night at 37 °C at 12g. The culture was centrifuged for 
10min at 4,000g. It was proceeded according to the manual. The purified DNA was dissolved in 
200µl TE buffer and stored at -20°C. 
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3. Results 
 
 
3.1  MDA-modifications exhibit differences in biological activity 
 
Malondialdehyde is a highly reactive aldhehyde and hardly ever found in free form in the human 
body, as it promptly forms stable adducts on proteins, lipids and DNA. For our experiments we 
modified a carrier protein, namely BSA, with MDA. Based on increasing published evidence, we 
postulated that certain MDA-epitopes are specifically recognized by the innate immune system. 
To prove this, I incubated BSA with MDA under various conditions, thereby generating different 
types of MDA adducts, including MDA-BSA, FHP-BSA, MAA-BSA and AA-BSA.  The per-
centage of modified amino groups in each preparation was assessed by TNBS assay, demonstrat-
ing a similar extent of modification for MAA-, FHP-, and MDA-BSA (Table 1). AA-
modifications appeared not to be successful. 
 
BSA 0,0 % 
MAA 84,6 % 
FHP 88,9 % 
MDA 79,0 % 
AA -3,7 % 
 
Table 1 Percentage of modified amino groups measured by TNBS test. 
 
BSA 0 0 
MAA 62 59 
FHP 12 11 
AA 1 1 
MDA  2 3 
H2O 2 3 
 
Table 2 BSA modifications show different fluorescence ability. 
 
Subsequently, I also measured the fluorescence in each preparation (Table 2), as described in 
Material & Methods. The negative controls, H2O, BSA (and AA-BSA), did not show any fluo-
rescence. Similarly, MDA-BSA showed no fluorescence. In contrast, FHP-BSA showed low, 
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and MAA-BSA high fluorescence. The fluorescence of the MAA-BSA is thought to be due to 
the enrichment of the MDHCS structure and the low fluorescence of FHP-BSA is likely due to 
some MDHDC epitopes in this modification. 
To assess and compare the biological activity of the differently modified protein preps, THP1 
cells were stimulated for 16h with the differentially modified proteins. After the treatment, su-
pernatants were assayed for IL-8 secretion by ELISA (Fig. 6A). THP1 cells showed a small, but 
significant increase in IL-8 secretion upon the stimulation with MDA-BSA. However, when 
stimulated with MAA-BSA, THP1 cells showed much higher IL-8 secretion (up to ~400pg/ml). 
As expected, stimulation with FHP-BSA also showed significant IL-8 secretion.  
Because the biological activity is highest in MAA-BSA, all following experiments were con-
ducted using this specific adduct. 
 
3.2. Excluding endotoxin contamination 
 
To rule out experimental artefacts as a result of endotoxin contamination, I performed LAL as-
says of our BSA preparations. Every single preparation had an endotoxin content of less than 
0,050EU/ml. THP1 cells lack CD14 and in our hands only respond to high doses of LPS 
(>1µg/ml) [27]. Because THP1 cells respond well to MAA-BSA stimuli, endotoxin-
contamination would require high amounts and should thus be easily detectable by LAL test. To 
further exclude endotoxin contamination, I performed a stimulation experiment in the presence 
of polymyxin B (Fig. 5), which has the ability to bind and neutralize endotoxin [28].  
For this experiment RAW macrophages were used. Cells were stimulated with BSA or MAA-
BSA in the presence or absence of keto-deoxyoctulosonate (KDO, the active component of LPS) 
and polymyxin B. KDO caused a general increase in MIP-2 secretion. Moreover, a synergistic 
effect of MAA-BSA and KDO could be observed. In the presence of polymyxin B, the effect of  
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Fig. 5 Polymyxin B neutralizes KDO but not MAA-BSA. ***<0,001, ns = non significant 
 
KDO was lost, whereas the MAA-BSA effect remained almost entirely unaffected. Finally, co-
stimulation with polymyxin B alone did not show any effect of the MIP-2 secretion induced by 
MAA-BSA. 
 
 
3.2 MAA-BSA induces a complex immune response 
 
 
Our research group as well as others have shown that MDA-adducts induce a chemokine re-
sponse in monocytes. To confirm this, THP1 cells (a human monocyte cell line) were stimulated 
with different concentrations of either MAA-BSA or BSA as a negative control for 16h (Fig. 
6B). Subsequently, the supernatants were taken and IL-8 levels were measured by ELISA. 
In this experiment, a dose-dependent effect of MAA-BSA on THP1 cells can be appreciated. 
Furthermore, the negative control BSA did not trigger any IL-8 secretion. However, a basal IL-8 
secretion can be observed. For all further experiments using THP1 cells, 50µg/ml of MAA-BSA 
was used, if not described otherwise. 
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Fig. 6 MAA-BSA acts as a danger signal. (A) Biological activity of different BSA modifications 
(100µg/ml each) (SN1:2).  MAA-BSA triggers (B) THP1 cells (SN1:2), (C) RAW cells (SN1:3), (D),(E) 
peritoneal macrophages and (F) BMDMs to secrete various chemokines. untr. = untreated. Bars represent 
mean +/- SD of biological triplicates. These data are representative examples of 2 (A, D) or 3 (B, C, E, F) 
independent experiments. **p<0,01, ***<0,001 
 
 
As we planned to investigate the role of MAA-BSA also in mice, it was important to confirm 
these results in a murine cell system. Therefore, I stimulated the immortalized peritoneal macro-
phage cell line RAW267.1 with different concentrations of MAA-BSA, and BSA as a negative 
control. 16h after stimulation, I measured the concentration of the chemokine KC (CxCl1) in the 
supernatant by ELISA. KC is the murine equivalent of human IL-8. Surprisingly, there was no 
KC secretion detectable.  
However, in the same experiment, a dose-dependent effect on MIP-2/Cxcl2 secretion was ob-
served (Fig. 6C). The fact that RAW macrophages responded to MAA-BSA by secreting MIP-2, 
was suggested that chemokines other than IL-8/KC may be affected as well.  
So far, all experiments had been carried out with immortalized cell lines. Therefore, we decided 
to test the response in primary cells. Therefore, I performed peritoneal lavages of wild type (WT) 
mice to isolate resident peritoneal macrophages. After seeding the cells over night, they were 
stimulated with different amounts of MAA-BSA for 16h. Upon MAA-BSA stimulation, perito-
neal macrophages responded by secreting KC (Fig. 6D) and MIP-2 (Fig. 6E) in a concentration 
dependent manner. However, only high concentrations of MAA-BSA were sufficient to induce a 
response in resident peritoneal macrophages.  
For this reason and also because of the limited number of peritoneal macrophages per mouse, we 
decided to obtain macrophages from a different source, namely the bone marrow. I isolated bone 
marrow of WT mice and differentiated macrophages (BMDMs) by addition of M-CSF. The dif-
ferentiated cells were treated with different concentrations of MAA-BSA. In contrast to perito-
neal macrophages, BMDMs were very sensitive to the MAA-BSA-treatment and showed a dose 
dependent KC secretion (Fig. 6F). Given that BMDMs responded very well to MAA-BSA, and 
the yield of cells following isolation from the bone marrow was much higher than from the peri-
toneum, all following experiments in primary cells were done with BMDMs.  
Macrophages can display different phenotypes [6]. Thus, we first addressed the question, 
whether MAA-stimulation induces a phenotypic change in macrophages. Freshly isolated bone 
marrow cells were seeded and differentiated into macrophages with M-CSF. Following complete 
 38
differentiation, cells were stimulated with MAA-BSA or BSA for 3.5h and RNA was isolated. 
Subsequently, I quantified the expression of the M1-specific gene iNOS (Fig. 7A) or the M2-
specific gene YM1 (Fig. 7B) by RT-qPCR. As seen in figure 7A, iNOS is upregulated upon 
MAA-BSA stimulation. In contrast, YM1, a M2 marker is downregulated upon MAA-BSA 
treatment. This suggested that stimulation of BMDM with MAA induces a shift towards an M1 
phenotype.  
Secondly, I assessed the MAA-specific response in M1 versus M2 macrophages. To elucidate 
this, BMDMs were isolated and subsequently polarized towards M1 with interferon-γ (IFN- γ) or 
M2 with interleukin-13 (IL-13). Successful polarization was confirmed by assessing the expres-
sion of iNOS (Fig. 7C) and YM1 (Fig. 7D) by RT-qPCR , respectively. The results given in Fig. 
7 demonstrate the successful polarization into M1 and M2 macrophages, allowing me to use the 
polarized macrophages to investigate their response towards MAA-BSA (Fig. 7E, 7F). Both 
CxCl1 and CxCl10 were found to be upregulated upon MAA-treatment.  
A           B 
 
 
 
 
 
 
 
  
 
C           D 
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E          F 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7 Macrophage phenotypes. Upregulation of (A) iNOS and (B) YM1 after treatment of M0 with 
MAA-BSA. Fold increase of (C) iNOS and (D) YM1 over untreated M0 to verify subclass polarization. 
MAA-BSA triggers upregulation of inflammatory genes in (E) M1 as well as in (F) M2. Bars represent 
mean +/- SD of biological triplicates. These data are representative examples of 2 independent experi-
ments. 
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Fig. 8 Upregulation of inflammatory genes upon MAA-BSA stimulation. (A) experiment of stimulated 
THP1 cells. (B) HO-1 is highly induced after MAA-BSA stimulation. (C) Time course experiment on 
BMDMs. Data points represent mean +/- SD of biological triplicates. 
 
We have shown that different inflammatory chemokines are upregulated, when cells of the in-
nate immune system are stimulated with MAA-BSA. To better understand the response to MAA-
BSA, I also screened for the induction of other inflammatory genes and the time points of their 
upregulation. Hence, I performed a time course experiment using THP1 cells. Cells were stimu-
lated for stimulation 0,1,2,4 and 8 hours and RNA was isolated to monitor the upregulation of 
different genes at each time point (Fig. 8A).  
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We first assessed the expression of IL-8 (CxCl8), MIP-2 (CxCl2), and MCP-1 (Ccl2). Upon the 
stimulation with MAA-BSA, all 3 genes were upregulated. CxCl2 was slightly induced (3x), 
whereas IL-8 (43x) and Ccl2 (14x) were highly upregulated. When stimulated with BSA, none 
of the genes showed an induction. The peak of upregulation was reached at 2h. Therefore, I 
chose this time point to screen for MAA-regulated genes on a genome wide scale using expres-
sion microarrays. Table 3 shows a list of the genes that were most strongly induced by MAA-
BSA in THP-1 cells. 
 
Fold in-
crease 
Gene Title Gene Sym-
bol 
36.20 chemokine (C-C motif) ligand 4 CCL4 
30.38 interleukin 1 receptor antagonist IL1RN 
10.92 ELOVL family member 7, elongation of long chain fatty acids 
(yeast) 
ELOVL7 
 
10.02 early growth response 2 EGR2 
9.65 interleukin 1 receptor antagonist IL1RN 
8.88 chemokine (C-C motif) ligand 3 CCL3 
8.83 chemokine (C-C motif) ligand 24 CCL24 
7.11 UL16 binding protein 2 ULBP2 
6.23 heme oxygenase (decycling) 1 HMOX1 
6.11 PR domain containing 1, with ZNF domain PRDM1 
5.82 5'-nucleotidase, ecto (CD73) NT5E 
5.76 pleckstrin homology-like domain, family A, member 1 PHLDA1 
5.66 platelet-derived growth factor alpha polypeptide PDGFA 
5.58 interleukin 1 receptor antagonist IL1RN 
5.51 perilipin 2 PLIN2 
5.44 carbonyl reductase 3 CBR3 
5.35 
 
v-maf musculoaponeurotic fibrosarcoma oncogene homolog B 
(avian) 
MAFB 
5.31 CDK5 regulatory subunit associated protein 2 CDK5RAP2 
5.15 dual specificity phosphatase 5 DUSP5 
5.04 human immunodeficiency virus type I enhancer binding protein 3 HIVEP3 
5.02 CD83 molecule CD83 
 
 42
Table 3 List of upregulated genes after stimulation of THP1 cells with MAA-BSA (only genes with at 
least 5x induction are shown). 
 
Surprisingly, none of the hitherto monitored cytokines were found in the list of high (>5x) 
upregulated genes. However, Ccl3, Ccl4 and Ccl24 which are closely related to Ccl2 were in-
duced. Interestingly, HO-1 (HMOX1), which is known to play a protective role against oxidative 
stress [29] was also induced. To verify this upregulation, I assessed the expression of HO-1 at 
various time points following MAA-stimulation in THP1 cells by RT-qPCR (Fig. 8B). Confirm-
ing the results of the microarray, HO1 was highly expressed upon MAA-BSA stimulation, but 
not after BSA stimulation. Interestingly, IL1RN was induced as well. This antagonist, modulates 
immune reactions by inhibiting IL1 alpha and beta (IL1b).  
To show whether the kinetics of gene expression following MDA-administration show a similar 
pattern in murine primary cells, I performed a time course experiment in BMDMs (Fig. 8C). 
Again RNA was isolated at different time points, following MAA-BSA stimulation, and the ex-
pression of inflammatory genes CxCl1 (KC), CxCl2, Ccl2 and the protective gene HO1 was as-
sessed. BMDMs stimulated with the negative control BSA showed no upregulation of the genes 
at any time. In contrast, MAA-BSA stimulated BMDMs express CxCl1 and CxCl2. Contrary to 
THP1 cells, BMDMs did not express Ccl2 in response to MAA-BSA. Corresponding with the 
THP1 time course, the peak of gene induction was around 2h. HO1 reached its peak at 4h and 
slightly decreased until 8h.  
 
In summary, MAA-BSA induces a complex response that is mainly characterized by the induc-
tion of genes known to be involved in the early inflammatory response. This demonstrates its 
capacity to act as an endogenous danger signal. 
 
 
3.3 Biological Relevance of MAA epitopes 
 
An important carrier of MDA-epitopes in vivo is represented by dying cells. In 2009, Chou et al. 
[30] generated apoptotic thymocytes by treating them with either dexamethasone or PMA, and 
found that late apoptotic cells carry MDA epitopes using an MDA-specific Ab.  
Apoptosis can be induced by various chemical agents and physical treatments. Therefore I com-
pared different ways of inducing apoptosis. Generating apoptotic THP1 cells by adding stauro-
sporine or dexamethasone was successful as assessed by 7-AAD and Annexin-V staining.  Vi-
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able cells are 7AAD and Annexin V double negative. Early apoptotic cells are Annexin V posi-
tive, but 7AAD negative. Most important, late apoptotic cells are 7AAD and Annexin V double 
positive. After gating the different markers, each subpopulation was stained with the MDA-
specific IgM Ab LRO4 for MDA epitopes. Surprisingly, under the experimental conditions used, 
I did not observe the generation of MDA-epitopes on late apoptotic THP1 cells. However, treat-
ment with the DNA-damage inducing agent etoposide induced late apoptotic cells with MDA-
epitopes on their surface (Fig. 9A, 9B).  
Because, the yield of late apoptotic cells after etoposide treatment was not satisfying, and higher 
concentrations did not increase the amount of late apoptotic cells, I switched to an alternative 
treatment. This time I decided to treat THP1 cells with UVA/UVB light. UVA light worked well 
in different concentrations, but again the amount of late apoptotic cells was unsatisfying. The use 
of UVB light induced high amounts of late apoptotic cells and high numbers of MDA-carrying 
apoptotic cells in different concentrations. I decided to irradiate THP1 cells with 40mJ UVB 
light (Fig. 9C, 9D) in the following experiments, as the amount of apoptotic cells generated was 
sufficient at a moderate dose.  
After identifying a reliable way to generate late apoptotic cells that carry MDA epitopes, I also 
tried the same treatment with RAW cells. Like THP1 cells, RAW macrophages were irradiated 
with different concentrations of UVA and UVB light, but the amount of apoptotic cells was dif-
ficult to assess (Fig. 9E, 9F). Unlike THP1 cells, RAW macrophages showed a high autofluores-
cence which made it impossible to gate individual sub-populations. However, an overall increase 
of LRO4-binding was observed following UVB irradiation, indicating a higher amount of MAA-
epitopes.  
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Fig. 9 Generation of apoptotic cells, carrying MDA epitopes. (A) Etoposide treated THP1 cells. Stained 
with 7AAD and Annexin V. (B) Gated cell-populations stained with LRO4. (C) THP1 cells irradiated 
with 40mJ UVB and stained with 7AAD and Annexin V. (D) Gated cell-populations stained with LRO4. 
(E) viable/untreated RAW macrophages were irradiated with (F) 40mJ UVB and stained with LRO4 for 
MDA epitopes (G). Different conditions were tested with similar results. Shown blots are representative. 
 
Subsequently, I wanted to investigate if MAA epitopes on late apoptotic cells have the same bio-
logical ‘danger’ effect as MAA-BSA. Indeed, when RAW cells were stimulated with apoptotic 
RAW cells (AC), an increase in MIP-2 secretion was observed similar to that observed with 
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MAA-BSA(Fig. 10). However, it needs to be demonstrated that this effect is indeed due to the 
presence of MAA-epitopes on late apoptotic cells. 
 
 
Fig. 10. Apoptotic cells (AC) induce MIP-2 secretion. Data is representative of 2 independent experi-
ments. Bars represent mean +/- SD of biological triplicates. This graph is a representative example of 3 
independent experiments.  
 
 
3.3.1 In vivo experiments 
 
In the previous chapters, I provided evidence that MAA-BSA acts as a danger signal and is 
found on apoptotic cells. As all these experiments were only done in vitro, we also wanted to test 
the ability of MAA-BSA to induce immune responses in vivo. The peritoneal cavity is an easy 
accessible, relatively closed system, and high concentrations of a given stimulus can be reached 
by local administration. Furthermore, most immunologically relevant cell types are present there.  
To assess the pro-inflammatory activity of MAA-BSA in vivo in a pilot experiment, I injected 
25µg/g mouse of BSA or MAA-BSA into the peritoneal cavity. After 2h, mice were sacrificed 
and the peritoneal cavity was lavaged. The obtained peritoneal cells were then stained for 
CD11b, Ly6C and Ly6G and subsequently analysed by FACS (Fig. 11A, 11B). Resident mono-
cytes were defined as Cd11b+Ly6C- and macrophages as Cd11bhigh Ly6C-. Moreover, neutrophils 
are CD11b+ Ly6C+ and inflammatory monocytes are CD11b+ Ly6Chigh. Additionally, the cells 
were stained for Ly6G, to distinguish between neutrophils (Ly6G+) and inflammatory monocytes 
(Ly6G-) (data not shown). Interestingly, the whole population of macrophages (a) is shifted upon 
MAA-BSA injection. This can be explained by the uptake of the fluorescent MAA-BSA which 
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interferes with the detection. Most striking, there was a significant influx of neutrophils (c) as 
well as of inflammatory monocytes (e). Furthermore, in this experiment, an increase of a cellular 
population (d) could be observed, which may represent other granulocytes, such as mast cells. In 
addition, we compared the percentages of granulocyte influx at 2h and 5h post injectionem (Fig. 
11C). The neutrophil influx peaked at 2h, while after 5h, the percentage of granulocytes started 
to normalize again. Neutrophil influx usually depends on secreted chemokines like IL-8. There-
fore, I also assayed the peritoneal lavage fluid for possible secretion of KC. I screened for KC 
secretion 2h and 5h after BSA or MAA-BSA injection (Fig. 11D), respectively. At the 2h time 
point, high KC secretion upon MAA-BSA injection was detected. After 5h, no KC was detect-
able. In contrast, injected BSA did not cause any KC secretion at both time points. Subsequently, 
BSA (n=7) or MAA (n=8) were injected into mice at the 2h time point (Fig. 11E), strengthening 
the data from the pilot experiment. 
 
A     B      
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Fig. 11 Intraperitoneal injections of MAA-BSA. (A), (B), (C) and (D) are graphs of one conducted ex-
periment. Following BSA (A) or MAA-BSA (B) injection, isolated peritoneal cells were stained for 
CD11b and Ly6C. (a) Monocytes, (b) macrophages, (c) neutrophils, (d) unknown and (e) inflammatory 
monocytes. (C) Granulocyte influx out of total peritoneal cells after 2h and 5h. (D) KC secretion upon 
BSA or MAA-BSA injection after 2 and 5h. (E) Peritoneal influx after IP injection (2h) of BSA (n=7) or 
MAA (n=8). **p<0,01 
 
Taken together, injections of MAA-BSA, but not BSA, cause secretion of inflammatory 
chemokines and influx of inflammatory cells, demonstrating that MAA-BSA can induce a sterile 
peritonitis, as both neutrophil influx and KC secretion are markers thereof [31]. 
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To test, whether apoptotic cells carrying MDA on their surface can elicit a similar response in 
the peritoneum, we performed a pilot experiment, in which apoptotic RAW cells were generated 
by UVB-irradiation and injected into the peritoneal cavity (n=2).  Injections of PBS and viable 
RAW cells were used as negative controls (n=2 each). After 2h, the peritoneal cavity was 
washed and cells stained for Cd11b and Ly6C (Fig. 12A, 12B). In addition, cells were stained for 
Ly6G to better discriminate between neutrophils and inflammatory monocytes. Similar to the 
MAA-BSA injection, injected apoptotic cells caused an increased influx of neutrophils and a 
modest influx of inflammatory monocytes in contrast to injected viable cells. Furthermore, the 
granulocyte influx was quantified, showing that apoptotic RAW cells mimic MAA-BSA (Fig. 
12C). Injection of PBS and viable RAW cells did not cause any granulocyte influx, whereas in-
jected apoptotic RAW cells caused a highly significant influx. Thus, apoptotic cells mimic to 
some extent the effects of MAA-BSA in vitro as well as in vivo. However, the experiments  
 
A     B               
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Fig. 12 After intraperitoneal injection of (A) viable or (B) apoptotic RAW cells, isolated peritoneal cells 
were stained for CD11b and Ly6C. (a) Monocytes, (b) macrophages, (c) neutrophils and (d) inflammatory 
monocytes. (C) Quantification of inflammatory cells out of total peritoneal cells. (n=2)  
 
have to be repeated with larger numbers of mice and it has to be demonstrated that MDA epi-
topes on the surface of apoptotic cells induce the neutrophil influx. 
Taken together, I have shown that MDA epitopes on apoptotic cells can act as an endogenous 
danger signal in vitro. Moreover, I elucidated that this effect is also present in vivo. Therefore I 
continued to investigate the response on a molecular level. 
 
 
3.4 Intracellular signalling 
 
The microarray expression data set I had generated from MAA-BSA stimulated THP1 cells was 
analyzed for enriched DNA motifs and enriched pathways as annotated in the KEGG-database 
(Kyoto Encyclopedia of Genes and Genomes) (Fig 13A). This analysis was conducted with 
GSEA (gene set enrichment analysis provided by the Broad Institute). Interestingly, most of the  
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Fig. 13 The intracellular response to MAA-BSA. (A) Analysis of microarray data for enriched pathways 
and DNA motifs. (B) MAA-BSA stimulation leads to increased phosphorylation of ERK. (C) Quantifica-
tion of ERK-phosphorylation after 15min of stimulation (3 pooled experiments). (D) The ERK inhibitor 
UO126 completely depletes MAA induced IL-8 secretion. *p<0,05, ***p<0,001 
 
genes upregulated by MAA-BSA treatment carried DNA motifs of MAPK regulated transcrip-
tion factors (13A, red circled), therefore indicating the involvement of the MAPK-pathway in 
MAA signalling. The pathway analysis revealed an enrichment of genes annotated as part of 1) 
the cytokine-cytokine receptor interaction pathway and 2) the biosynthesis of steroids pathway. 
The enrichment of the former can be explained by the fact that many cytokines and chemokines 
were induced upon MAA-BSA stimulation. Enrichment of the latter may be the result of a biased 
annotation, as many enzymes involved in antioxidant response also play a role in steroid biosyn-
thesis.  
Extracellular signal regulated kinases (ERK) belong to the mitogen activated protein kinases 
(MAPK) and regulate a plethora of important cellular functions including proliferation, secre-
tion, migration and apoptosis [32, 33]. To prove this hypothesis, THP1 cells were stimulated for  
different time points with either MAA-BSA or BSA. Cell lysates were analyzed for possible 
phosphorylation of ERK by Western Blotting (Fig 13B). ERK was found to be highly phos-
phorylated upon MAA-BSA treatment at each time point. In contrast, stimulation with BSA did 
not cause an increase in ERK-phosphorylation. Levels of pERK were assessed after 15min and 
densitometrically quantified (Fig 13C). Phosphorylation of ERK (p-ERK) was first normalized 
to total ERK (t-ERK), BSA controls were set as 100%, and the increase of phosphorylation was 
calculated. There was a statistical significance (p<0.05) in phosphorylation between BSA and 
MAA-BSA stimulation. To address the question if phosphorylation of ERK is crucial for MAA 
signalling, I then tested the effect of the ERK inhibitor UO126 on MAA induced IL-8 secretion 
in THP1 cells (Fig. 13D).  
As reported above, THP1 cells secreted IL-8 upon MAA-BSA stimulation. When UO126 was 
added, IL-8 secretion was completely blunted. This data suggest that MAA induced IL-8 secre-
tion is ERK dependent. 
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3.5 MAA binds to TLRs 
 
After delineation of the most important intracellular mediators, we decided to focus on identify-
ing the receptors involved in MAA signalling. To identify possible binding partners of MAA, we  
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Fig. 14 MAA pulldown in RAW lysate. (A) MAA-PL beads compete with MAA-BSA or MDA-LDL for 
binding to MDA-specific natural antibodies. (B) Silverstain of one representative pulldown with MAA-
PL or PL beads in RAW lysate. (C) Samples were handed over to the mass spectrometry facility and ana-
lyzed. The figure shows MAA-binding partners which were found in at least 50% of the conducted ex-
periments. 
 
used a proteomic approach. We coupled sepharose beads to either MAA-polylysine or polylysine 
as a negative control and used them to pull down MDA-binding proteins from cell lysate ob-
tained from RAW-cells. To verify the biological activity of our newly generated MAA-PL beads 
an immunocompetition experiment was conducted (Fig. 14A). MAA-PL beads completely com-
pete with MAA-BSA. Therefore we could proceed with the pulldown experiment. Aliquots of 
the eluted samples were run on a gel and visualized by a silver stain (Fig. 14B). 
When the pulldowns of MAA-PL beads and PL- beads were compared (Fig. 14B), many addi-
tional bands were identified in the MAA-PL pulldown compared to the PL pulldown (e.g. bands 
~60kDA and ~150kDA). Eluted samples were subsequently analyzed by Keiryn Bennett 
(CeMM), using tandem mass spectrometry [34]. Following the subtraction of PL binding part-
ners, we show in Fig. 14C only the MAA binding partners which appeared in at least 66% of the 
experiments. This list of binding partners reveals that MAA interacts with various proteins of the 
MAPK pathway, for instance MAPK1 and MAPK2. These results are congruent with the already 
shown data that MAPK pathways are crucial for signalling. However, receptors on the cell sur-
face could not be detected as MAA binding partners with this method. 
 
As the uptake of MDA-epitopes is mediated by SR-A [35], a possible role is conceivable. There-
fore we treated THP1 cells with Fucoidan, a SR-A agonist (Fig. 15). If SR-A plays a role in 
MAA signalling, Fucoidan should compete with MAA and therefore decrease IL-8 secretion. 
THP1 cells were pre-incubated 1h together with Fucoidan and then stimulated with MAA or 
LPS. As expected, Fucoidan had no effect on LPS induced effects. In contrast, Fucoidan treat-
ment diminished MAA-BSA induced IL-8 secretion. This indicates a possible role for SR-A in 
MAA signalling. Fucoidan treatment diminished but did not ablate IL-8 secretion. Hence, other 
receptors may play a role. However, no membrane proteins or receptors were found in the pull-
down experiment, which may be due to technical limitations [36] of our approach. SR-A-ligands 
synergize with TLR4 ligands in the context of macrophage cell death [13]. Moreover, another 
paper showed that oxidized phospholipids, which are CD36 ligands, acts through a heterodimer 
of TLR4 and TLR6 [37]. To assess the role of TLR4 in MAA induced inflammation, I isolated 
BMDMs from WT and TLR4-/- mice and treated them with MAA-BSA. 
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Fig. 15  Impact of Fucoidan (50 and 5 µg/ml) on IL-8 secretion (SN 1:2). Data is representative of 2 simi-
lar experiments. **p<0,01, ns = not significant 
 
Macrophages obtained from mice lacking the scavenger receptor CD36, which is responsible for 
the uptake of phosphocholine-decorated molecules [38] , were used as an additional control. WT 
and CD36-/- BMDMs responded to the MAA-BSA stimulation by secreting KC (Fig. 16A). In 
contrast, TLR4-/- BMDMs did not secrete KC in response to the MAA-BSA stimuli. BMDMs 
from the same knockout mice were stimulated with BSA or MAA-BSA for 3h, RNA was iso-
lated and expression of inflammatory genes was quantified by RT-qPCR (Fig. 16B). Upon 
stimulation with MAA-BSA, BMDMs from WT and CD36-/- induce expression  
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Fig. 16 Screen for different pattern recognition receptors. BMDMs from WT, TLR4-/- and CD36-/- mice 
were stimulated with MAA-BSA and checked by ELISA for KC secretion (A) or by qPCR for upregula-
tion of CxCl1, CxCl2 and CxCL10 (B). BMDMs from WT, TLR2-/- and CD14-/- mice were stimulated 
with MAA-BSA and checked for KC secretion (C) or upregulation of CxCl1, CxCl2 and CxCl10 (D). 
Bars represent mean +/- SD of biological triplicates. Data are representative of 2 independent experi-
ments. 
 
of CxCl1, CxCl2 and CxCl10. According to the previous ELISA results, none of these genes 
were upregulated in TLR4-/-. Therefore, TLR4 seems to play a crucial role in MAA signalling.  
The TLR4 complex consists, as previously described, of TLR4 itself as a dimer, MD2, and the 
co-receptor CD14. To test, whether CD14 is necessary for MDA-induced chemokine-secretion, 
BMDMs from CD14-/- mice were isolated and stimulated. In a first experiment, levels of secreted 
KC following MAA-stimulation were assessed by ELISA (Fig.16C). In contrast to wt cells, 
CD14-/- BMDMs did not induce KC secretion upon MAA-BSA stimulation. In line with this, 
expression of CxCl1, CxCl2 and CxCl10 was not induced in CD14-/- BMDM 2h after stimulation 
with MAA-BSA. As control, cells were stimulated with LPS, which induces a residual, but sig-
nificantly reduced response in CD14-/- macrophages. Combining the ELISA and qPCR results, 
CD14 seems to be necessary for MAA-signalling. Therefore the results indicate that several 
components of the TLR4 complex are needed for the response to MAA-BSA.  
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We confirmed the involvement of TLR4 in the model of MAA-induced sterile peritonitis that we 
introduced in chapter 3.3.1, using TLR4-/- mice. After injection of MAA-BSA into TLR4-/- mice 
(n=10), levels of KC in the peritoneal lavage fluid remained low as measured by ELISA (Fig. 
17A). On the other hand, injection of MAA-BSA into WT mice (n=3) caused significant KC 
secretion. These results indicate a crucial role of TLR4 in MAA-induced sterile inflammation in 
vivo. 
According to our data, blocking of TLR4 should diminish MAA signalling. Therefore, I stimu-
lated THP1 cells with MAA-BSA and LPS and added Eritoran to some of the samples (Fig. 
17B). The chemical structure of Eritoran is similar to LPS and thus it acts as a TLR4 antagonist 
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Fig. 17 The role of TLR4-/- in MAA signalling. (A) Amount of KC in the peritoneal lavage after 2h of 
intraperitoneal injections of MAA-BSA into WT (n=3) or TLR4-/- (n=10) mice. (B) Eritoran interferes 
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with LPS but not with MAA-BSA. These data are representative of 2 experiments. *p<0,05, 
**p<0,01, ns = not significant 
 
and blocks TLR4 induced immune responses [39]. Consistent with the literature, Eritoran com-
peted with LPS also in our setting, thereby decreasing LPS induced IL-8 secretion. Importantly, 
MAA-BSA stimulation was not affected by Eritoran pretreatment. This data suggest that MAA-
BSA does not bind in the same way as LPS. Therefore, it either binds at a different position or 
other receptors are involved. 
Because v-(2-carboxyethyl) pyrrole (CEP), another oxidation specific epitope, was shown to 
signal through TLR2 [40], I stimulated TLR2-/- BMDMs with MAA-BSA (Fig. 16C). Similar to 
CD14-/- and TLR4-/- mice, BMDMs from TLR2-/- showed no response to the MAA-BSA stimuli, 
suggesting also an important role for this receptor in MAA signalling. Again, we confirmed this 
data by qPCR (Fig. 16D). As expected, TLR2-/- did also not show any response to Pam3CSK, a 
common TLR2 ligand. 
 
Importantly, the expression analysis confirmed the results described in Fig. 16C: MAA-BSA 
failed to induce the expression of chemokines in TLR2-deficient macrophages. None of the 
tested inflammatory genes were upregulated in the TLR2-/- mice. ELISA and qPCR results to-
gether suggest a crucial role for TLR2 in MAA specific signalling. 
 
After elucidating various receptors which are involved in MAA signalling, I wanted to explore 
the possibility whether MAA-BSA physically interacts with them. Therefore, I used an ELISA  
A       
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Fig. 18 MAA-BSA binds to TLR2. (A) TLR2 Fc chimera binds to Pam3CSK and MAA-BSA. Data are 
representative of 3 independent experiments. (B) MAA-BSA competes with the TLR2 Fc chimera. 
 
based binding assay based on Fc-receptor chimeras of TLR2, as described in the materials and 
methods section. Fc chimeras are constructed by genetic fusion between the extracellular domain 
of the receptors and the Fc portions from IgG antibodies and can be easily detected by labelled 
Fc specific 2nd ABs. Fc-TLR 2 bound to coated MAA-BSA as well as to coated Pam3CSK, 
which was used as a positive control (Fig. 18A). Furthermore specific binding of MAA-BSA to 
TLR2 was confirmed in a competition ELISA experiment (Fig. 18B). MAA-BSA, but not BSA, 
competes with the TLR2 Fc chimera for binding to coated MAA-BSA. 
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4. Discussion 
 
MDA is a highly reactive aldehyde, which immediately reacts with aminogroups on proteins and 
lipids, generating a variety of different adducts, including MAA and FHP. For our experiments, I 
modified BSA with MDA. By adjusting the pH and incubation time, and by adding acetalde-
hyde, I was able to enrich for MAA-type adducts. Here I show that the generated MAA-BSA 
modification causes increased IL-8 secretion, when THP1 cells are stimulated with it, identifying 
MAA-adducts as biologically active MDA-modifications. In contrast, other types of aldehyde-
modifications, such as simple MDA-BSA, caused only very few IL-8 secretion. FHP induced 
intermediate IL-8 secretion, probably due to residual generation of the MAA-adduct. These data 
suggest that MDHDC modifications, which are enriched in MAA-BSA, are responsible for the 
observed inflammatory response. This inflammatory potential of MAA supports the notion that 
also other oxidation epitopes than CEP and minimally modified low-density lipoprotein 
(mmLDL), induce inflammation [40, 41]  Furthermore, I demonstrate that the response is not to 
due to any endotoxin contamination of our MAA-BSA modifications. All preparations used in 
this manuscript were tested for endotoxin by the LAL-assay. Moreover, the LPS-binding mole-
cule polymyxin B failed to inhibit MAA-BSA induced chemokine-secretion. In addition, THP1 
cells, which are expressing very low amounts of the LPS-co-receptor CD14 [27] and therefore 
would not respond to low doses of endotoxin, are very sensitive to MAA-BSA treatment.  
The hypothesis, that MAA-BSA acts as a danger signal, is further supported as both human as 
well as mouse cell lines (THP1 and RAW), and also primary mouse cells (peritoneal macro-
phages and BMDMs)  respond to MAA-BSA treatment by the secretion of a number of proin-
flammatory chemokines, including IL-8/KC and MIP-2. Additionally, I show that protective, 
antioxidant genes like HO-1 are also induced. Furthermore, different macrophage subtypes (M1 
and M2) respond similarly to this stimulus. Taken together, I have shown that MAA-BSA in-
duces a complex inflammatory response. As MAA is an oxidation specific epitope and is gener-
ated endogenously, it is suggested that MAA is a major inducer of sterile inflammation. The fact 
that natural antibodies (like LRO4), which are found in plasma without any previous infections, 
and complement factor H recognize and bind MAA, further strengthens our hypothesis that 
MAA is a major inducer of sterile inflammation.  
I further demonstrate that UVB treated monocytes and macrophages that undergo apoptosis and 
carry MDA/MAA epitopes. This is in line with previously reported findings [42]. When THP1 
cells were stimulated with apoptotic THP1 cells, no inflammatory response was detectable. Pos-
sible explanations could be, that the detected epitopes on apoptotic THP1 cells generated by 
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UVB-irradiation are mainly simple MDA adducts or the density of MAA epitopes is too low to 
elicit a response. Additionally, I show that apoptotic RAW cells carry MDA/MAA epitopes and 
cause an inflammatory response. Given that MAA epitopes are present on apoptotic cells, MAA 
qualifies as endogenous DAMP (damage associated molecular pattern). 
UVB irradiated, apoptotic RAW cells were found to mimic the MAA-BSA effect, inducing a 
robust inflammatory response, probably due to an enrichment of MAA epitopes on their sur-
faces. However, a neutralization experiment with LRO4 (or other MDA-specific Abs) still needs 
to be done to prove, that the effect of apoptotic RAW cells is mediated by MDA epitopes. 
I further found that MDA elicits a sterile peritonitis in vivo. Following MAA-BSA injection into 
the peritoneal cavity of mice, I observed an influx of granulocytes and high KC secretion in the 
lavage fluid. These hallmarks are consistent with the already well established model of LPS in-
duced sterile peritonitis [43]. It is interesting that the MAA-BSA induced inflammation was 
cleared rapidly in 5 hours, as no KC is anymore detectable and the amount of granulocytes were 
significantly decreased in contrast to the 2 hours time point. Therefore it can be suggested that 
accumulation of MAA causes a fast inflammatory response, which is cleared quickly and effec-
tively to prevent further damage. Furthermore, I provide evidence, that apoptotic RAW cells 
mimic the effects of MAA-BSA also in vivo. Like MAA-BSA, injected apoptotic cells cause the 
influx of a considerable amount of granulocytes.  
Genomic analysis of the gene expression changes caused by MAA stimulation suggested an in-
volvement of MAPK pathways. Indeed, western blot analysis indicated higher ERK1/2 phos-
phorylation after MAA-BSA treatment. We further show that ERK activity is necessary for 
MAA-induced chemokine-secretion, as ERK inhibition by UO126 completely abolished IL-8 
secretion. Based on this data, it is believed that intracellular signalling through activation of 
ERK1/2 and further activation of the JNK pathway, which activates transcription factors.  
Interestingly, our proteomic approach to identify cellular MAA-binding proteins in RAW lysate 
revealed many potential MAA specific binding partners. However, as all of them were intracellu-
lar proteins, this assay did not help in delineating involved extracellular receptors. Together with 
the already shown interaction of SR-A and MAA [35], it is an indication for a possible role of 
phagocytosis in MAA signalling and has to be investigated in future experiments. Independent of 
phagocytosis, SR-A could still be necessary for MAA signalling.  To elucidate this possibility, 
the SR-A antagonist Fucoidan was used. The stimulation together with Fucoidan revealed, that 
this antagonist interferes with the MAA stimuli but not with LPS pointing towards a possible 
role of SR-A in MAA-induced chemokine secretion. Because SR-A has no known intracellular 
signalling cascade [44], other receptors are likely to be involved.  
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TLR4 has been shown to mediate the inflammatory response to other oxidation epitopes [37]. 
Furthermore, SR-A ligands have been reported to act synergistically with TLR4-ligands in in-
ducing macrophage cell death [13, 37]. Using TLR4 deficient macrophages, I was able to show a 
crucial role for TLR4 in MAA-induced inflammation both in vitro as well as in vivo. In BMDMs 
the co-receptor CD14 is also necessary for MAA-signalling, as all the knockout mice did not 
respond anymore to the stimuli. In contrast, THP1 cells, which lack CD14 [27], respond nor-
mally to MAA-BSA, suggesting a need for CD14 only in primary cells. According to the data 
obtained, blocking of TLR4 should deplete IL-8 secretion. By using the TLR4 antagonist Erito-
ran, I was able to show that unlike with LPS, MAA-induced IL-8 secretion was not diminished.  
A recent publication [40] reported that CEP, another oxidation epitope, is TLR2 dependent. 
TLR2 deficiency caused an ablation of the macrophage response to MAA-BSA.  
Using an in vitro binding assay based on Fc-receptor-chimeras, I was able to show that MAA 
directly interacts with TLR2 and specific binding was proved in a competition experiment. How-
ever, further binding studies with TLR4 have to be conducted. 
 
A working model for MAA-induced signalling based on the data presented here would be fol-
lowing: MAA-BSA binds directly to TLR2, which subsequently forms a dimer with TLR4. 
Moreover the whole dimer complex is stabilized by co-receptor CD14. Following, dimerization, 
the complex signals through phosphorylation of ERK1/2 and subsequent activation of transcrip-
tion factors. However, the possible role of SR-A is yet not fully understood and will require fur-
ther investigation. 
One approach would be to express all receptors in all possible combinations in HEK293T cells 
and check the transcriptional response to MAA in a luciferase reporter assay. A possible pro-
moter to identify transcriptional response would be AP1, as the microarray data suggests an 
upregulation of the JNK pathway. Furthermore, dimerization of TLR2 and TLR4 should be 
proved by fluorescence microscopy and the binding to TLR2 has to be confirmed by colocaliza-
tion with fluorescent MAA-BSA. However, achieving a pure MAA-solution is impossible. 
Therefore, FHP will always be a part of the MAA-BSA modification and vice versa. Fur further 
studies, it will be advisable to use one defined adduct, as with the protocols applied in this thesis, 
only mixtures can be generated. 
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6. Appendix 
 
 
6.1 Abstract (English) 
 
 
Malondialdehyde (MDA) per se is a highly reactive aldehyde generated during lipid breakdown 
that forms adducts on amino groups. One of the main generated adducts is the Malondialdehyde-
acetaldehyde-adduct, further named MAA. MAA mainly consists of the ring structure 4-methyl-
1,4-dihydropyridine-3,5-dicarbaldehyde (MDHDC). These epitopes are found on the surface of 
apoptotic and necrotic cells and on the surface of apoptotic blebs (microparticles) and accumu-
late in many diseases, such as atherosclerosis. 
We show that MAA causes a fast and complex inflammatory response in vitro and in vivo. 
Macrophages and monocytes immediately respond to this epitope by secreting various pro-
inflammatory chemokines. The recognition of MAA by macrophages involves the pattern-
recognition-receptors (PRRs) TLR4 and TLR2. Additionally, CD14 is crucial for eliciting a re-
sponse to MAA. Conducted binding assays prove a direct binding of MAA to TLR2 as well as to 
TREM1. Moreover, competition assays suggest a role for scavenger receptor A (SR-A) in MAA-
signalling.  
We show that stimulation with MAA-BSA leads to an upregulation of MAPK pathways on the 
genomic level. Specifically, ERK1/2 is phosphorylated in response to MAA-BSA treatment. 
Using an ERK-specific inhibitor, we show that the response to MAA-BSA is ERK-dependent.  
Taken together we present evidence that MAA represents a novel damage-associated-molecular-
pattern (DAMP) which is abundant in inflammatory conditions and diseases associated with it. A 
better understanding of MAA signalling could identify novel therapeutical targets and thereby 
lead to a better treatment of these diseases. 
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6.2 Abstract (German) 
 
 
Malondialdehyd (MDA) ist ein hochreaktives Aldehyd, das während der Peroxidation von Lipi-
den (Fettsäuren) produziert wird. Es reagiert sofort mit Acetaldehyd und freien Aminogruppen 
und bildet dabei eine Reihe verschiedener chemischer Strukturen (Epitope). Ein sehr häufig ge-
bildetes Epitop ist das Malondialdehyd-Acetaldehyd-Addukt (MAA). Dieses bezeichnet vorran-
gig eine Ring-Struktur namens 4-methyl-1,4-dihydropyridine-3,5-dicarbaldehyde (MDHDC). 
MAA Epitope findet man an der Oberfläche von apoptotischen und nekrotischen Zellen, sowie 
an der Oberfläche von Mikropartikeln.  
In dieser Master Thesis zeigen wir, dass eine Stimulation mit MAA schon nach kurzer Zeit 
Makrophagen und Monozyten zur Sekretion von inflammatorischen Chemokinen veranlasst. 
Unsere Resultate weisen darauf hin, dass Macrophagen MAA mittels TLR2 und TLR4 erkennen. 
CD14 scheint dabei ebenso eine wichtige Funktion zu erfüllen. Weiters zeigen wir mittels in 
vitro Bindungsstudien, dass MAA an TLR2 bindet. Überraschenderweise fanden wir auch her-
aus, dass MAA an TREM1 bindet. Bisher ist kein TREM1 Ligand bekannt, daher ist MAA der 
erste nachgewiesene, direkte Interaktionspartner.  
Wir  zeigen, dass nach Bindung an diese Pattern-Recognition-Rezeptoren (PRRs) MAPK-
pathways  hochreguliert werden. Eine Stimulation mit MAA führte zu einer erhöhten Phosphory-
lierung von ERK1/2. Inhibition von ERK mit einem künstlichen Inhibitor führte zu einer redu-
zierten Sekretion von Chemokinen nach MAA-BSA Stimulation.  
Zusammenfassend, beschreiben wir ein neues damage-associated-molecular-pattern (DAMP), 
welches in vielen Krankheitsbildern vorkommt. Ein besseres Verständnis, von den von MAA 
ausgelösten Immunreaktionen, könnte in Zukunft zu einer besseren Behandlung von  Krankhei-
ten führen, in denen MAA eine wichtige Rolle spielt. 
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